Open main menu
Search Ctrl + K
Free Trial
Loading...
Gain Therapeutics, Inc.
Watch
Pharmaceutical Preparations
NASDAQ.GANX
4800 Hampden Lane, Suite 200, Bethesda, MD, 20814
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Financials
10-Q
Quarterly Filing
14 Nov 24
10-Q
Quarterly Filing
08 Aug 24
10-Q
Quarterly Filing
14 May 24
10-K
Fiscal Year 2023
26 Mar 24
10-Q
Quarterly Filing
14 Nov 23
10-Q
Quarterly Filing
10 Aug 23
10-Q
Quarterly Filing
12 May 23
Ownership
4
Mack Gene
12 Aug 24
4
Islam Khalid
12 Aug 24
4
Richman Eric I
01 Jul 24
4
Nicaise Claude
26 Jun 24
4
Islam Khalid
26 Jun 24
4
Hasler Hans Peter
26 Jun 24
4
Richman Eric I
26 Jun 24
News
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
14 Nov 24
8-K
Other Events
21 Oct 24
8-K
Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
08 Oct 24
8-K
Entry Into A Material Definitive Agreement, Financial Statements And Exhibits
06 Sep 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
08 Aug 24
8-K
Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing
12 Jul 24
8-K
Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
09 Jul 24
Proxies
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
26 Apr 24
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
26 Apr 24
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
28 Apr 23
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
28 Apr 23
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
13 May 22
Prospectuses and Registrations
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
19 Sep 24
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
06 Sep 24
FWP
Free Writing Prospectuses - Filing Under Securities Act Rules 163/433.
01 Jul 24
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
17 Jun 24
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
13 Jun 24
424B3
Prospectus Filed Pursuant To Rule 424(b)(3).
02 Jan 24
S-1
Basic Registration Form Used To Register Securities Pursuant To The Securities Act.
19 Dec 23
Other
ARS
Scanned Paper Annual Report Submission.
26 Apr 24
EFFECT
Notice Of Effectiveness For A Previously Filed Sec Document.
29 Dec 23
CORRESP
Correspondence With The Sec.
22 Dec 23
UPLOAD
Letter From The Sec.
21 Dec 23
ARS
Scanned Paper Annual Report Submission.
28 Apr 23
EFFECT
Notice Of Effectiveness For A Previously Filed Sec Document.
01 Jun 22
CORRESP
Correspondence With The Sec.
31 May 22